Vertex Pharmaceuticals (VRTX) Cash & Current Investments (2009 - 2026)
Vertex Pharmaceuticals' quarterly Cash & Current Investments came in at $7.2 billion in Q1 2026, up 16.86% year-on-year from $6.2 billion in Q1 2025, and up 9.66% quarter-over-quarter from $6.6 billion in Q4 2025.
Vertex Pharmaceuticals has reported Cash & Current Investments for 18 years, with the latest figure at $7.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 16.86% year-over-year to $7.2 billion; the trailing twelve-month figure through Mar 2026 stood at $7.2 billion (up 16.86% YoY), and the FY2025 full-year result was $6.6 billion, up 8.05% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $7.2 billion, up from $6.6 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $11.9 billion in Q3 2023, with the low at $5.8 billion in Q2 2024.
- Average Cash & Current Investments over 5 years is $8.5 billion, with a median of $8.2 billion recorded in 2022.
- Year-over-year, Cash & Current Investments soared 43.24% in 2022 and sank 48.42% in 2024.
- Tracing VRTX's Cash & Current Investments over 5 years: stood at $10.8 billion in 2022, then advanced by 4.08% to $11.2 billion in 2023, then plunged by 45.48% to $6.1 billion in 2024, then advanced by 8.05% to $6.6 billion in 2025, then grew by 9.66% to $7.2 billion in 2026.
- The last three Cash & Current Investments figures came in at $7.2 billion (Q1 2026), $6.6 billion (Q4 2025), and $6.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.25 Bn |
| Dec 31, 2025 | 6.61 Bn |
| Sep 30, 2025 | 6.29 Bn |
| Jun 30, 2025 | 6.38 Bn |
| Mar 31, 2025 | 6.20 Bn |
| Dec 31, 2024 | 6.12 Bn |
| Sep 30, 2024 | 6.52 Bn |
| Jun 30, 2024 | 5.80 Bn |
| Mar 31, 2024 | 10.17 Bn |
| Dec 31, 2023 | 11.22 Bn |
| Sep 30, 2023 | 11.93 Bn |
| Jun 30, 2023 | 11.24 Bn |
| Mar 31, 2023 | 10.41 Bn |
| Dec 31, 2022 | 10.78 Bn |
| Sep 30, 2022 | 9.77 Bn |
| Jun 30, 2022 | 9.25 Bn |
| Mar 31, 2022 | 8.24 Bn |
| Dec 31, 2021 | 7.52 Bn |
| Sep 30, 2021 | 6.96 Bn |
| Jun 30, 2021 | 6.71 Bn |
| Mar 31, 2021 | 6.92 Bn |
| Dec 31, 2020 | 6.66 Bn |
| Sep 30, 2020 | 6.15 Bn |
| Jun 30, 2020 | 5.45 Bn |
| Mar 31, 2020 | 4.19 Bn |
| Dec 31, 2019 | 3.81 Bn |
| Sep 30, 2019 | 4.00 Bn |
| Jun 30, 2019 | 3.95 Bn |
| Mar 31, 2019 | 3.48 Bn |
| Dec 31, 2018 | 3.17 Bn |
| Sep 30, 2018 | 3.06 Bn |
| Jun 30, 2018 | 2.77 Bn |
| Mar 31, 2018 | 2.48 Bn |
| Dec 31, 2017 | 2.09 Bn |
| Sep 30, 2017 | 1.81 Bn |
| Jun 30, 2017 | 1.67 Bn |
| Mar 31, 2017 | 449.67 Mn |
| Dec 31, 2016 | 1.43 Bn |
| Sep 30, 2016 | 1.13 Bn |
| Jun 30, 2016 | 1.07 Bn |
| Mar 31, 2016 | 1.03 Bn |
| Dec 31, 2015 | 1.04 Bn |
| Sep 30, 2015 | 1.01 Bn |
| Jun 30, 2015 | 1.02 Bn |
| Mar 31, 2015 | 1.18 Bn |
| Dec 31, 2014 | 1.39 Bn |
| Sep 30, 2014 | 1.48 Bn |
| Jun 30, 2014 | 1.22 Bn |
| Mar 31, 2014 | 1.32 Bn |
| Dec 31, 2013 | 1.47 Bn |
| Sep 30, 2013 | 1.42 Bn |
| Jun 30, 2013 | 1.43 Bn |
| Mar 31, 2013 | 1.24 Bn |
| Dec 31, 2012 | 1.32 Bn |
| Sep 30, 2012 | 1.30 Bn |
| Jun 30, 2012 | 1.22 Bn |
| Mar 31, 2012 | 1.17 Bn |
| Dec 31, 2011 | 968.92 Mn |
| Sep 30, 2011 | 658.69 Mn |
| Jun 13, 2011 | 4.58 Mn |
| Mar 31, 2011 | 823.45 Mn |
| Dec 31, 2010 | 1.03 Bn |
| Sep 30, 2010 | 1.20 Bn |
| Jun 30, 2010 | 979.15 Mn |
| Mar 31, 2010 | 1.09 Bn |
| Dec 31, 2009 | 1.28 Bn |
| Sep 30, 2009 | 559.13 Mn |
| Jun 30, 2009 | 408.95 Mn |
| Mar 31, 2009 | 602.20 Mn |